Tasigna® - FASS Allmänhet

FASS.se - läkemedelsinformation för vårdpersonal, patienter och veterinärer

Nilotinib - Wikipedia

Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of ...

Tasigna: Uses, Dosage, Side Effects & Warnings - Drugs.com

Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia. Includes Tasigna side effects, interactions and indications.

HIGHLIGHTS OF PRESCRIBING INFORMATION ...

FULL PRESCRIBING INFORMATION WARNING: QT PROLONGATION AND SUDDEN DEATHS Tasigna prolongs the QT interval. Prior to Tasigna administration and periodically, monitor ...

VIDAL - TASIGNA 150 mg gél - Synthèse - VIDAL - La base ...

TASIGNA 150 mg gél : Synthèse, Formes et présentations, Composition, Indications, Posologie et mode d'administration, Contre-indications, Mises en garde et ...

TASIGNA 200 mg 112 kapsül Klinik Özellikler

TASIGNA 200 mg 112 kapsül sağlık profesyonelleri için Kısa Ürün Bilgisi klinik özellikleri.Ayrıca farmasötik formu, farmakolojik özellikleri, kalitatif ve ...

Tasigna 200 mg hard capsules - Summary of Product ...

Tasigna 200 mg hard capsules - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

Dasatinib, nilotinib and imatinib for untreated chronic ...

Evidence-based recommendations on dasatinib (Sprycel), nilotinib (Tasigna) and imatinib (Glivec) for untreated chronic myeloid leukaemia in adults

Thomson One

Trusted Financial Content For Superior Decision Making. Thomson ONE delivers a broad and deep range of financial content, all within a workspace that's geared to your ...

Legemiddelsøk - Legemiddelverket

Statens legemiddelverk skal sikre at alle legemidler som blir brukt i Norge har god kvalitet, er trygge å bruke og har ønsket virkning.